Better-than-expected sales of some of its new products, including Skyrizi and Rinvoq, helped AbbVie handle a sharp decline in sales of former cash-cow product Humira in the last quarter of 2023. The ...
Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, ...
Novo Nordisk A/S won approval to sell a high-dose version of its blockbuster Wegovy obesity shot in the US, allowing it to ...
Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...
© 2026 Forbes Media LLC. All Rights Reserved.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results